Premium
Drug‐eluting versus bare‐metal stents for saphenous vein graft lesions
Author(s) -
Conte Sean M.,
Florisson Daniel S.,
De Bono Joshua A.,
Vale Peter R.
Publication year - 2019
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.14659
Subject(s) - medicine , bare metal , saphenous vein graft , percutaneous coronary intervention , surgery , drug , percutaneous , vein , stent , cardiology , artery , restenosis , myocardial infarction , psychiatry
A best evidence topic was written addressing the question ‘in patients with saphenous vein graft lesions requiring percutaneous coronary intervention, do long‐term clinical outcomes differ between drug‐eluting and bare‐metal stents?’ Altogether 1466 papers were found, of which seven represented the best evidence. Although one major recent randomised trial was neutral, the weight of earlier evidence supports drug‐eluting stents as standard of care. Bare‐metal stents may represent a reasonable, efficacious, and less expensive alternative to drug‐eluting stents in well selected patient groups.